Purchase Order 75P00218P00261
- Not listed
- This federal contract award was issued by the Department of Health and Human Services (HHS) to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $940,522.50 firm fixed price purchase order is for the delivery of flu vaccines. Seqirus USA Inc. has previously received awards from other federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Centers for Disease Control and...
- The U.S. Department of Health and Human Services has awarded a $22,428.00 firm-fixed-price purchase order contract to Seqirus USA Inc., a global biotechnology company, for the delivery of flu vaccines during the 2024-2025 season. This award is not a set-aside contract. Seqirus, through its Seqirus Usa, Inc. division, is a major supplier of influenza vaccines to various federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Health and Human...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services to Seqirus USA Inc., a global biotechnology company, for the delivery of influenza vaccines. The contract, valued at $1,608,584.60, does not have a set-aside designation. Seqirus USA Inc. has a history of providing influenza vaccines to various federal government customers, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Department...
- The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...
- The Department of Health and Human Services awarded a $225,812 firm fixed price purchase order to Seqirus USA Inc. for the delivery of flu vaccine QUAD. Seqirus USA Inc. is a global biotechnology company that specializes in influenza vaccines. This award did not use a set-aside. Seqirus USA Inc. has received numerous federal contracts to supply influenza vaccines to agencies such as the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Centers for Disease Control...
- This federal contract award to Seqirus USA Inc. is for the delivery of flu vaccines. The $1,241,993.00 fixed-price purchase order was awarded on June 30, 2020 by the U.S. Department of Health and Human Services and has a completion date of July 30, 2020. Seqirus is a global biotechnology company that specializes in the manufacturing and delivery of influenza vaccines to various federal government agencies. The company has been awarded multiple Indefinite Delivery Contracts (IDCs) with agencies...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccines. The contract is for the delivery of flu vaccines, with a potential value of $227,430.00. Seqirus USA Inc. has previously received contracts from various government agencies, including the Department of Defense, Department of Justice Bureau of Prisons, and Department of Health and...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $187,670.00 contract is for the delivery of flu vaccines, with a completion date of October 15, 2018. Seqirus USA Inc. is the prime contractor and no set-aside was used for this award. Seqirus USA Inc. is a division of Seqirus Usa, Inc. and has a history of providing influenza...
- This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $196,435.80 firm fixed price delivery order is for the procurement of flu vaccines, with a completion date of October 15, 2021. Seqirus USA Inc. has previously received several influenza vaccine contracts from federal agencies such as the Department of Defense, Department of Justice Bureau of Prisons, and...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $300,259.50 firm fixed price delivery order is for the provision of influenza vaccines for the 2017/2018 flu season. Seqirus USA Inc. has a history of providing influenza vaccines to federal government customers, including the Department of Defense, Department of Justice Bureau of Prisons, and...
This federal contract award was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $101,795.87 firm fixed price contract is for the delivery of flu vaccines and does not have a set-aside designation. Seqirus USA Inc.'s Seqirus Usa, Inc. Division has previously held influenza vaccine contracts with various federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and HHS. The company currently holds several active Indefinite Delivery Indefinite Quantity (IDIQ) contracts to provide influenza vaccines, including a potential $46 million IDIQ with the Defense Logistics Agency Troop Support Medical and a $69 million IDIQ with the VA National Acquisition Center. These IDIQ contracts allow the government to issue task orders to procure required vaccines each flu season.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Change Order | $74.7k | 8/16/18 | |
| Not listed | Not listed | $27.1k | 7/16/18 |